Developing and maintaining relationships with experienced sites, key opinion leaders (KOLs), and patient advocacy groups is vital to the success of any study. It’s especially important in dermatology, inflammation, gastroenterology research, and aesthetics research, where unique patient populations, study designs, and regulatory demands make connections even more integral to trial success.
Symbio’s networks include the industry’s leading therapeutically focused clinical research, offering crucial insights, stronger site selection, and more.
Key Opinion Leader Network
We’ve been specializing in indication specific clinical research for more than 25 years. As such, we’ve developed exceptional relationships with best-in-class KOLs across the globe, offering real-world insights into dermatology, aesthetics, gastroenterology, and inflammation research.
Site Network
As a specialty CRO, we’ve established a superior network of 5,000+ sites and investigators across 50 countries, helping us streamline recruitment, deliver shorter enrollment timelines, and accelerate site selection.
Dow Development
California, U.S.
Symbio
New York, U.S.
Symbio
Münster, Germany
Symbio
India (Remote)
Symbio
Melbourne, Australia
We are continuously looking to expand our database with experienced clinical research sites and investigators from all therapeutic backgrounds.
Patient Advocacy Partnerships
We partner with patient advisory groups to design and execute studies that work in the real world and meet patient needs. Because when expertise and collaboration come together, they create a ripple of confidence that is felt all the way to the patient.
